BACKGROUND: The analgesic efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) is well established, and these agents often form an integral part of posttraumatic pain management. However, potentially deleterious effects of resulting prostaglandin suppression on fracture-healing have been suggested. METHODS: A systematic literature review involving searches of electronic databases and online sources was performed to identify articles exploring the influence of NSAIDs on fracture-healing. RESULTS: A structured search approach identified 316 papers as potentially relevant to the topic, and these were manually reviewed. The majority described small-scale studies that were retrospective or observational in nature, with limited control of potentially confounding variables, or presented little key information that was not also present in other studies. CONCLUSIONS: Although increasing evidence from animal studies suggests that cyclooxygenase-2 (COX-2) inhibition suppresses early fracture-healing, in vivo studies involving human subjects have not provided convincing evidence to substantiate this concern. We found no robust evidence to attest to a significant and appreciable patient detriment resulting from the short-term use of NSAIDs following a fracture. The balance of evidence in the available literature appears to suggest that a short-duration NSAID regimen is a safe and effective supplement to other modes of post-fracture pain control, without a significantly increased risk of sequelae related to disrupted healing.
BACKGROUND: The analgesic efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) is well established, and these agents often form an integral part of posttraumatic pain management. However, potentially deleterious effects of resulting prostaglandin suppression on fracture-healing have been suggested. METHODS: A systematic literature review involving searches of electronic databases and online sources was performed to identify articles exploring the influence of NSAIDs on fracture-healing. RESULTS: A structured search approach identified 316 papers as potentially relevant to the topic, and these were manually reviewed. The majority described small-scale studies that were retrospective or observational in nature, with limited control of potentially confounding variables, or presented little key information that was not also present in other studies. CONCLUSIONS: Although increasing evidence from animal studies suggests that cyclooxygenase-2 (COX-2) inhibition suppresses early fracture-healing, in vivo studies involving human subjects have not provided convincing evidence to substantiate this concern. We found no robust evidence to attest to a significant and appreciable patient detriment resulting from the short-term use of NSAIDs following a fracture. The balance of evidence in the available literature appears to suggest that a short-duration NSAID regimen is a safe and effective supplement to other modes of post-fracture pain control, without a significantly increased risk of sequelae related to disrupted healing.
Authors: Luke G McVeigh; Anthony J Perugini; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena Journal: Curr Osteoporos Rep Date: 2020-10 Impact factor: 5.096
Authors: Michael Bottlang; Stanley Tsai; Emily K Bliven; Brigitte von Rechenberg; Karina Klein; Peter Augat; Julia Henschel; Daniel C Fitzpatrick; Steven M Madey Journal: J Bone Joint Surg Am Date: 2016-03-16 Impact factor: 5.284
Authors: Avraam Ploumis; Jayne M Donovan; Mobolaji O Olurinde; Dana M Clark; Jason C Wu; Douglas J Sohn; Kevin C O'Connor Journal: J Spinal Cord Med Date: 2014-05-13 Impact factor: 1.985
Authors: Riika Merivirta; Mikko Pitkänen; Jouko Alanen; Elina Haapoja; Mari Koivisto; Kristiina Kuusniemi Journal: J Pain Res Date: 2015-01-16 Impact factor: 3.133
Authors: Russell P Main; Sandra J Shefelbine; Lee B Meakin; Matthew J Silva; Marjolein C H van der Meulen; Bettina M Willie Journal: J Orthop Res Date: 2019-10-23 Impact factor: 3.102